| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/15/2010 | US20100092468 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |
| 04/15/2010 | US20100092463 Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| 04/15/2010 | US20100092444 Platelet rich plasma formulations for cardiac treatments |
| 04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 04/15/2010 | US20100092423 Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 04/15/2010 | CA2739715A1 Treating or preventing gout |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174674A1 Methods and compositions for healing and repair of articular cartilage |
| 04/14/2010 | EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof |
| 04/14/2010 | EP2173896A2 Prognostic method for the determination of the suitability of biopharmaceutical treatment |
| 04/14/2010 | EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 04/14/2010 | EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/14/2010 | EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof |
| 04/14/2010 | EP1507533B1 Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/14/2010 | EP1409016B1 Antibodies to opgl |
| 04/14/2010 | CN1887317B Externally applied liniment for treating rheumatic and rheumatoid arthritis and its preparation |
| 04/14/2010 | CN1778296B Long-acting preparation for tatin medicine |
| 04/14/2010 | CN101693736A Novel peptides |
| 04/14/2010 | CN101693688A Indeno isoquinolone derivatives, preparation process and medical application thereof |
| 04/14/2010 | CN101693106A Application of metallothionein on preparing medicines for treating diskal hernia and hyperosteogeny |
| 04/14/2010 | CN101693072A Traditional Chinese medicine composition for treating cervical and lumber vertebra diseases |
| 04/14/2010 | CN101693069A External preparation for treating soft tissue injuries and preparation method thereof |
| 04/14/2010 | CN101693060A Uron medicinal liquor for activating blood, eliminating dampness and removing spur and preparation method thereof |
| 04/14/2010 | CN101693056A External medicine bag for treating articular osteoid diseases and using method thereof |
| 04/14/2010 | CN101693052A Violet light pellet and preparation method thereof |
| 04/14/2010 | CN101693051A Preparation method and composition of clerodendranthus spicatus extract |
| 04/14/2010 | CN101693049A Sambucus chinensis extract and preparation method thereof |
| 04/14/2010 | CN101693029A Oral preparation having improved bioavailability |
| 04/14/2010 | CN101693022A Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 04/14/2010 | CN101692902A Food compositions for lowering and releasing uric acid and preventing gout |
| 04/14/2010 | CN101692900A Natto seaweed capsule and preparation method thereof |
| 04/14/2010 | CN101181456B Plaster for curing bone fracture assimilation and preparation method thereof |
| 04/14/2010 | CN101129353B Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 04/14/2010 | CN101053615B Medicinal composition for treating bone fracture and injury and its preparation method |
| 04/14/2010 | CN101015580B PH-dependent composite bone peptide preparation, preparing method and use thereof |
| 04/13/2010 | US7696247 Lipid-based nitric oxide donors |
| 04/13/2010 | US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease |
| 04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
| 04/13/2010 | CA2443802C Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2431308C Regulation of angiogenesis with zinc finger proteins |
| 04/13/2010 | CA2430363C Compounds and their uses |
| 04/13/2010 | CA2422377C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base |
| 04/13/2010 | CA2360680C Antioxidant compositions and methods for companion animals |
| 04/08/2010 | WO2010039920A2 Boldine compounds for promoting bone growth |
| 04/08/2010 | WO2010039742A2 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 04/08/2010 | WO2010038771A1 Light-stabilized pharmaceutical composition |
| 04/08/2010 | WO2010038756A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 04/08/2010 | WO2010038714A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 04/08/2010 | WO2010038610A1 Novel cartilage cell proliferation and differentiation inducer |
| 04/08/2010 | WO2010038465A1 8-substituted isoquinoline derivative and use thereof |
| 04/08/2010 | WO2010038153A1 Use of sox transcription factor acti\ators for stimulating chondrogenesis |
| 04/08/2010 | WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 04/08/2010 | WO2010037536A1 N-protected guanidine-substituted furans, thiophenes, and pyrrols as cysteine protease inhibitors |
| 04/08/2010 | WO2010037213A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 04/08/2010 | WO2010001096A3 Treatment |
| 04/08/2010 | US20100087544 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| 04/08/2010 | US20100087527 Curcumin Derivatives |
| 04/08/2010 | US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
| 04/08/2010 | US20100087506 Cyclic amine compound |
| 04/08/2010 | US20100087480 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 04/08/2010 | US20100087449 Heteroarylamide pyrimidone compounds |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087437 Novel Potassium Channel Blockers |
| 04/08/2010 | US20100087428 Novel Potassium Channel Blockers |
| 04/08/2010 | US20100087413 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| 04/08/2010 | US20100086942 Compounds |
| 04/08/2010 | US20100086620 Bone Cement Composition and Method of Making the Same |
| 04/08/2010 | US20100086598 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | CA2739345A1 Lactic acid bacterium having high oxalic acid decomposition ability |
| 04/08/2010 | CA2738660A1 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2736914A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 04/07/2010 | EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY |
| 04/07/2010 | EP2172226A1 Method of fixing and expressing physiologically active substance |
| 04/07/2010 | EP2172192A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
| 04/07/2010 | EP2170879A1 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 04/07/2010 | EP2170878A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteoporosis comprising the same |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP1979351B1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | EP1254237B1 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690800A Externally used medicament for expelling rheumatism, promoting blood circulation and relieving pain and preparation method thereof |
| 04/07/2010 | CN101690797A Traditional Chinese medicine for treating rheumatism and rheumatoid diseases |
| 04/07/2010 | CN101690793A Method for detecting quality of bone strengthening capsules |
| 04/07/2010 | CN101690792A Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc |
| 04/07/2010 | CN101690788A Throat-clearing three dispersion granules |
| 04/07/2010 | CN101690779A Traditional Chinese medicine for oral taking for treating scapulohumeral periarthritis |
| 04/07/2010 | CN101690769A External medicament for treating hyperosteogeny and preparation method thereof |
| 04/07/2010 | CN101690768A Vein and artery relieving pills for impediment of sinew |
| 04/07/2010 | CN101690761A Anti-osteomyelitis drug and preparation technology thereof |
| 04/07/2010 | CN101690750A External medicine for curing hyperosteogeny |
| 04/07/2010 | CN101690746A Chinese herbal preparation for treating injuries from falls, fractures, contusions and strains |
| 04/07/2010 | CN101690728A Composition for treating osteoarthritis |
| 04/07/2010 | CN101690727A Medicament for treating arthritis and preparation method thereof |
| 04/07/2010 | CN101690716A Calcium alginate-chitosan sustained-release microsphere carrying growth hormone and application thereof |